These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31167509)

  • 1. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update.
    Lo Sasso B; Agnello L; Bivona G; Bellia C; Ciaccio M
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31167509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebrospinal fluid diagnostics in multiple sclerosis].
    Ruprecht K; Tumani H
    Nervenarzt; 2016 Dec; 87(12):1282-1287. PubMed ID: 27649986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
    Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligoclonal bands: clinical utility and interpretation cues.
    Carta S; Ferraro D; Ferrari S; Briani C; Mariotto S
    Crit Rev Clin Lab Sci; 2022 Sep; 59(6):391-404. PubMed ID: 35277112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
    Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
    J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
    Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
    J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
    Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
    Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.
    Gastaldi M; Zardini E; Franciotta D
    Expert Rev Mol Diagn; 2017 Jan; 17(1):31-46. PubMed ID: 27911122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
    Krakauer M; Schaldemose Nielsen H; Jensen J; Sellebjerg F
    Acta Neurol Scand; 1998 Sep; 98(3):161-5. PubMed ID: 9786611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis.
    Lin MW; Suan D; Lenton K; Henniker T; Burke T; Vucic S; Fulcher DA
    Pathology; 2012 Apr; 44(3):248-50. PubMed ID: 22406478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
    Dobson R; Topping J; Davis A; Thompson E; Giovannoni G
    Acta Neurol Scand; 2013 Nov; 128(5):321-7. PubMed ID: 23465040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.